In:
British Journal of Haematology, Wiley
Abstract:
Individuals with telomere biology disorders (TBDs) have very short telomeres, high risk of bone marrow failure (BMF), and reduced survival. Using data from TBD patients, a mean leukocyte Southern blot telomere length (TL) of 5 kilobases (kb) was estimated as the ‘telomere brink’ at which human survival is markedly reduced. However, the shortest telomere, not the mean TL, signals replicative senescence. We used the Telomere Shortest Length Assay (TeSLA) to tally TL of all 46 chromosomes in blood‐derived DNA and examined its relationship with TBDs. Patients ( n = 18) had much shorter mean TL (TeSmTL) (2.54 ± 0.41 kb vs. 4.48 ± 0.52 kb, p 〈 0.0001) and more telomeres 〈 3 kb than controls ( n = 22) (70.43 ± 8.76% vs. 33.05 ± 6.93%, p 〈 0.0001). The proportion of ultrashort telomeres ( 〈 1.6 kb) was also higher in patients than controls (39.29 ± 10.69% vs. 10.40 ± 4.09%, p 〈 0.0001). TeS 〈 1.6 kb was associated with severe ( n = 11) compared with non‐severe ( n = 7) BMF ( p = 0.027). Patients with multi‐organ manifestations ( n = 10) had more telomeres 〈 1.6 kb than those with one affected organ system ( n = 8) ( p = 0.029). Findings suggest that TBD clinical manifestations are associated with a disproportionately higher number of haematopoietic cell telomeres reaching a telomere brink, whose length at the single telomere level is yet to be determined.
Type of Medium:
Online Resource
ISSN:
0007-1048
,
1365-2141
Language:
English
Publisher:
Wiley
Publication Date:
2023
detail.hit.zdb_id:
1475751-5
Permalink
